KR102500324B1 - Apparatus for treatment of submucosal tissue equipped with motion detection sensor - Google Patents

Abstract

An apparatus for treating submucosal tissue according to an embodiment of the present invention includes a probe member including a head part accessing the mucous membrane of a treatment site and a main body part connected to the head part; an electrode installed in the head part and applying an electrical signal to blood vessels of the submucosal tissue of the mucosa; a motion detection sensor installed in the head unit and detecting an operation of the head unit; and a control unit connected to the main body and adjusting the output of the electrical signal according to the motion of the head unit detected by the motion detection sensor.

Description

Treatment device for submucosal tissue equipped with a motion detection sensor

The present invention relates to a treatment device for submucosal tissue equipped with a motion detection sensor, and more particularly, to a motion detection sensor capable of controlling the output of an electric signal by detecting a moving motion of a head unit in which an electrode for applying an electric signal is installed. It relates to a treatment device for submucosal tissue.

BACKGROUND OF THE INVENTION [0002] The mucous membrane of the body refers to the inner wall of a mid-cavity organ that is in direct contact with the outside, such as the respiratory tract, digestive tract, urogenital tract, and the like. More specifically, mucous membranes in the body may be classified into oral mucosa, nasal mucosa, laryngopharyngeal mucosa, bronchial mucosa, vaginal mucosa, glans mucosa, urethral mucosa, anal mucosa, etc., depending on location.

These mucosal and submucosal tissues can be damaged as a result of an inflammatory response. Aging, dry environment, physical damage caused by repetitive friction, and exposure to chemicals increase the inflammatory response of the mucosal and submucosa and activate the proteolytic system of the extracellular matrix. Macrophage cells released into tissues through blood vessels cause inflammation and release matrix metalloproteinases (MMPs). These MMPs degrade collagen and elastin molecules after the inflammatory process. MMP-1 degrades collagen I and collagen III, while MMP-12 most actively causes degradation of elastin. Excessive collagen and elastin degradation results in flaccid and elongation of mucosal tissue.

On the other hand, various diseases or abnormal symptoms may occur in the mucous membrane, and appropriate treatment should be performed according to the symptoms. As one of the abnormal mucosal symptoms of the body, there is vaginal atony, in which the female vaginal mucosa is stretched. The vaginal mucosa of a woman is composed of a tissue with good elasticity, but when sexual intercourse and childbirth are repeatedly performed, as the vaginal mucosa gradually elongates, elasticity and frictional force decrease and contractility decreases. In this way, when the contractility of the vaginal mucosa is reduced, pressure and friction are reduced during sexual intercourse, which not only reduces sexual pleasure, but also expands to urinary incontinence and problems of self-confidence, leading to psychological atrophy.

Since the elongation of the vaginal mucosa is related to the generation of new blood vessels in the vaginal submucosa, it may be helpful to maintain contractility of the vaginal mucosa by suppressing excessive generation of new blood vessels at an early stage. However, there are few studies on techniques for treating vaginal abnormalities (vaginal atony) by acting on the blood vessels of the vaginal submucosal tissue.

An object of the present invention is to provide a submucosal tissue treatment device capable of preventing burns, hygienic and economically improved.

An apparatus for treating submucosal tissue according to an embodiment of the present invention includes a probe member including a head part accessing the mucous membrane of a treatment site and a main body part connected to the head part; an electrode installed in the head part and applying an electrical signal to blood vessels of the submucosal tissue of the mucosa; a motion detection sensor installed in the head unit and detecting an operation of the head unit; and a control unit connected to the main body and adjusting the output of the electrical signal according to the motion of the head unit detected by the motion detection sensor.

It is installed on the main body and further includes a drive motor for rotating the head, and the drive motor may be controlled by the control unit.

It is installed on the main body and may further include a direction indicating unit displaying a rotation direction of the head unit.

The head part and the body part may be detachable.

An electrical coupling part including an electrical coupling pin installed in the body portion and an electrical coupling plate installed in the head portion, wherein the electrical coupling pin is inserted into the electrical coupling groove of the electrical coupling plate to be electrically coupled. can

The detachable part may further include a detachable part attaching or detaching the head part from the main body part, and the detachable part may include a hook part installed in the main body part, and a hooking part installed in the head part and coupled with the hook part.

The motion detection sensor may include a gyro sensor or an acceleration sensor.

a guide member in which the probe member is selectively rotatably and linearly movable, and guides a position of the electrode relative to the mucous membrane of the treatment area; and a movement guide unit for guiding rotation and linear movement of the probe member with respect to the guide member.

In the submucosal tissue treatment device according to an embodiment of the present invention, a motion detection sensor for detecting the motion of the head part is installed in the head part, and a driving motor for rotating the head part is installed in the main body part, thereby rotating and linearly moving the electrode. Since it is possible to change the position of the electrode by detecting it, it is possible to prevent burns of the mucous membrane by preventing continuous irradiation of high-frequency signals to the mucous membrane at the same location due to carelessness of the operator.

In addition, by manufacturing the head and body of the probe member in a detachable manner, only the head in which electrodes are installed can be replaced, which is hygienic and economical.

1 is a schematic perspective view of a submucosal tissue treatment device according to an embodiment of the present invention.
FIG. 2 is a front view of the submucosal tissue treatment device of FIG. 1 in a state in which the head and main body are separated.
FIG. 3 is a rear view of the submucosal tissue treatment device of FIG. 1 in a state in which the head and main body are separated.
Figure 4 is a cross-sectional view of Figure 1;
5 and 6 are diagrams illustrating an operating state of the detachable unit of the submucosal tissue treatment device according to an embodiment of the present invention.
7 is a cross-sectional view showing a state in which guide members of the submucosal tissue treatment device according to an embodiment of the present invention are installed in the head part and the main body part.
8 is an enlarged perspective view of a guide member and a movement guide unit of the submucosal tissue treatment device according to an embodiment of the present invention.

Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings so that those skilled in the art can easily carry out the present invention. This invention may be embodied in many different forms and is not limited to the embodiments set forth herein.

1 is a schematic perspective view of a submucosal tissue treatment device according to an embodiment of the present invention, FIG. 2 is a front view of the submucosal tissue treatment device of FIG. 1 in a state in which the head and main body are separated, and FIG. 1 is a rear view of the submucosal tissue treatment device in a state where the head and main body are separated, and FIG. 4 is a cross-sectional view of FIG. 1 .

1 to 4, the submucosal tissue treatment device according to an embodiment of the present invention includes a probe member 100, an electrode 200, a motion detection sensor 300, a driving motor 400, and a control unit. 500, a direction indicating unit 600, an electrical coupling unit 710, a detachable unit 720, a guide member 800, and a movement guide unit 900.

The probe member 100 may include a head portion 110 that approaches the mucous membrane of the treatment site and a body portion 120 connected to the head portion 110 .

The head portion 110 is formed at an end of the body portion 120 to have a larger size than the body portion 120, and may enter the vagina and contact the vaginal mucosa. The shape and structure of the head unit 110 may be variously changed according to required conditions and design specifications. Preferably, the outer surface of the head portion 110 may be formed in a curved shape to minimize mucosal wounds when the head portion 110 is inserted into the body. For example, the head portion 110 may be formed in an elliptical shape. In this way, by forming the head portion 110 in an elliptical shape similar to the entrance of the body, entry of the head portion 110 towards the inside of the body can be performed more easily, and the head portion 110 enters the inside of the body. When it becomes available, it can reduce the pressure applied to the patient, thereby obtaining an advantageous effect of enabling mucosal treatment in a more comfortable environment. In some cases, it is also possible to form the head portion 110 in a spherical shape, or in a spherical shape with a concave central portion or other geometrical shapes.

The body portion 120 may be formed in a rod shape having a predetermined length. For example, the body portion 120 may be a straight rod having a circular cross section. In some cases, the main body 120 may also be formed to have an elliptical or polygonal cross-section. Alternatively, it is also possible to form the body portion 120 in a bent shape or to configure the body portion by combining two or more members.

The body portion 120 is preferably formed to have a sufficient length and thickness so that an operator can easily grip and manipulate it, and the present invention is not limited or limited by the length and thickness of the body portion 120 .

The electrode 200 is installed on the head part 110 and can treat diseases of the submucosal tissue by applying an electrical signal to the blood vessels of the submucosal tissue of the mucous membrane. Here, applying an electrical signal while the electrode 200 is in contact with the mucous membrane is defined as applying an electrical signal to the blood vessels of the submucosal tissue in order to improve mucosal disease or abnormal symptoms, depending on the type and characteristics of the electrical signal. The present invention is not limited or limited by. In one example, electrode 200 may be configured to apply radio frequency (RF) energy to the vaginal mucosa. In some cases, it is also possible that the electrode 200 is configured to apply other types of energy, such as microwave or ultrasonic waves. As the electrode 200, a conventional monopolar electrode 200 or a bipolar electrode 200 may be used, and the present invention is not limited or limited by the type of the electrode 200.

The electrode 200 may be a monopolar electrode or a bipolar electrode, and a pair of electrodes is formed by splitting the electrode into two and placing an insulator in the middle, or by splitting the electrode into two or more plural pieces and placing an insulator between them, such as splitting a watermelon. A pair of electrodes may be formed so that one electrode operates as a (+) electrode and the adjacent electrode acts as a (-) electrode to exhibit positive polarity. Also, the electrical signal applied from the electrode 200 may be an alternating current electrical signal. The alternating current electrical signal has a property of effectively inducing a thermal coagulation reaction in blood vessels in the treated tissue. Alternatively, the electrical signal applied from the electrode 200 may be a DC electrical signal. The direct current electrical signal has a property of helping to deliver a substance such as a drug into the treated tissue or destroying the tissue. Preferably, the electric signal applied from the electrode 200 has a frequency of 0.3 ~ 300Mhz. More preferably, the electric signal applied from the electrode 200 has a frequency of 0.5 ~ 10 Mhz. Most preferably, the electric signal applied from the electrode 200 has a frequency of 0.5 to 3 Mhz. In this way, by allowing the electric signal applied from the electrode 200 to have a frequency of 0.3 to 300 MHz, an appropriate thermal response can be caused to the blood vessels of the submucosal tissue, which is a cause or aggravating factor.

The outer surface of the electrode 200 may be formed as a spherical curved surface, and electrical signals may be emitted in a radial shape through the curved surface. The electrode 200 may be formed of a material having excellent electrical conductivity and excellent thermal conductivity, and the material of the electrode 200 may be variously changed according to required conditions. For example, the electrode 200 may be formed of stainless, copper, aluminum, gold, silver, or the like.

The motion detection sensor 300 is installed on the head unit 110 and can detect motion of the head unit 110 . That is, the motion detection sensor 300 may detect whether the electrode 200 installed on the head unit 110 rotates or moves linearly. The motion detection sensor 300 may include a gyro sensor or an acceleration sensor.

The driving motor 400 is installed on the main body 120 and can rotate the head 110 . The driving motor 400 may be controlled by the control unit 500 .

The control unit 500 is connected to the body unit 120 and can adjust the output of an electrical signal according to the motion of the head unit 110 detected by the motion detection sensor 300 . That is, the control unit 500 reads data about the motion of the head unit 110 detected by the motion detection sensor 300 and determines rotation and linear movement of the electrode 200 to adjust the output of the electric signal. .

Accordingly, when the movement of the head unit 110 in which the electrode 200 is installed is not sensed, the motion detection sensor 300 transmits the motion to the control unit 500 to stop the output of the electrical signal to prevent mucosal burns. In addition, the control unit 500 may drive the driving motor 400 to rotate the head unit 110 in which the electrode 200 is installed. Therefore, by adjusting the position of the electrode 200, it is possible to accurately irradiate the electrical signal to the mucous membrane of the treatment site.

The direction indicator 600 is installed on the main body 120 and may indicate the rotation direction of the head 110 . Since the exact rotation angle of the electrode 200 can be known using the direction indicator 600, the rotation angle of the electrode 200 can be accurately adjusted. The direction indicating unit 600 may be implemented as a liquid crystal display unit, but is not necessarily limited thereto and may be implemented in various structures.

Conventionally, when inserting the probe member 100 into the mucous membrane of a treatment site for a procedure, since the operator cannot visually check the probe member, the probe member is rotated and moved linearly by hand to perform treatment. That is, when the part inserted into the human body (head part) and the part (body part) that is not inserted into the human body by gripping by the operator rotate integrally, the angle of rotation of the probe member arbitrarily without the operator visually checking it. and the depth of the linear movement, it is not easy to accurately control the rotation angle of the probe member and the depth of the linear movement. Therefore, if the operator does not pay attention or lacks experience, the treatment area that has already been treated may not be treated again or moved at an appropriate time, resulting in a risk of burns.

However, in the submucosal tissue treatment device according to an embodiment of the present invention, a motion detection sensor 300 for detecting motion of the head part 110 is installed in the head part 110, and the head part ( By including the driving motor 400 for rotating the 110, it can be configured to rotate only the head 110 in a state where the main body 120 held by the operator's hand does not move. Therefore, since the position of the electrode 200 can be changed by detecting rotation and linear movement of the electrode 200, it is possible to prevent burns of the mucous membrane by preventing continuous irradiation of high-frequency signals to the mucous membrane at the same location due to carelessness of the operator. can

Meanwhile, the head part 110 and the main body part 120 are detachable. To this end, the head part 110 and the body part 120 may be provided with an electrical coupling part 710 and a detachable part 720 . The electrical coupling part 710 allows the head part 110 and the body part 120 to be electrically detachable from each other, and the detachable part 720 allows the head part 110 and the body part 120 to be physically detachable from each other. let it do

First, the electrical coupling unit 710 may include an electrical coupling pin 711 installed on the body portion 120 and an electrical coupling plate 712 installed on the head portion 110 . The electrical coupling pin 711 may be inserted into the electrical coupling groove of the electrical coupling plate 712 and electrically coupled thereto.

Therefore, when the head part 110 and the main body part 120 are detachable from each other, the electrical coupler 710 can easily turn on and off the head part 110 and the main body part 120 electrically. . The electrical coupler 710 may have a pogo pin structure, but is not necessarily limited thereto and various structures are possible.

5 and 6 are diagrams illustrating an operating state of the detachable unit of the submucosal tissue treatment device according to an embodiment of the present invention.

As shown in FIGS. 5 and 6 , the detachable part 720 may physically attach and detach the head part 110 and the main body part 120 .

The detachable part 720 may include a hook part 721 installed on the body part 120 and a hooking part 722 installed on the head part 110 and coupled with the hook part 721 .

As shown in FIG. 5 , the hooked end of the hook part 721 is fixed to the hooking part 722 so that the main body part 120 and the head part 110 can be physically coupled to each other. And, as shown in FIG. 6, the hook-shaped end is separated from the hooking part 722 by moving the switch connected to the hook-shaped end of the hook part 721, and the body part 120 and the head part 110 can be physically separated from each other.

In this way, by manufacturing the head portion 110 and the body portion 120 of the probe member 100 in a detachable manner, only the head portion 110 in which the electrode 200 is installed can be replaced, which is hygienic and economical.

7 is a cross-sectional view showing a state in which guide members of the apparatus for treating submucosal tissue according to an embodiment of the present invention are installed in the head and body parts, and FIG. 8 is a apparatus for treating submucosal tissue according to an embodiment of the present invention. It is an enlarged perspective view of the guide member and the moving guide part of

As shown in FIGS. 7 and 8 , the guide member 800 accommodates the probe member 100 to be selectively rotatably and linearly movable, and may guide the position of the electrode 200 relative to the mucous membrane of the treatment site. . The guide member 800 is fixed in position with respect to the mucous membrane, and the probe member 100 may be selectively rotatably accommodated in the guide member 800 . In this way, by fixing the position of the guide member 800 relative to the mucous membrane and allowing the probe member 100 to rotate relative to the guide member 800, the electrode 200 mounted on the probe member 100 is placed in the vagina. Even if it is inserted inside and covered, the operator can recognize the position of the electrode 200 based on the guide member 800.

The guide member 800 communicates with a guide body portion 810 having a first accommodating hole 812 in which the probe member 100 is rotatably accommodated and communicates with the first accommodating hole 812, and the probe member 100 The second accommodating hole 822 rotatably accommodated is formed and may include an extension guide portion 820 integrally formed with the guide body portion 810. Preferably, the extended guide part 820 is formed to have a cross-sectional area that gradually expands from a proximal end adjacent to the guide body part 810 to a distal end. For example, the extension guide part 820 may be formed to have a cross-sectional area that gradually expands from one end to the other end like a trumpet. At this time, the extension guide portion 820 may be formed in a circular, polygonal or elliptical shape, and the present invention is not limited or limited by the shape and structure of the extension guide portion 820 . Preferably, the extended guide part 820 may be formed to a size that can be fixed from the outside of the vaginal inlet (a size that can be hung from the outside of the vaginal inlet).

The reference position display unit 802 may be formed on the outer surface of the guide member 800 in the form of a protrusion or a recessed groove. The rotational position of the electrode 200 relative to the mucous membrane may be controlled based on the reference position display unit 802 .

The movement guide unit 900 may guide rotation and linear movement of the probe member with respect to the guide member 800 . Here, guiding the linear movement of the probe member 100 with respect to the guide member 800 means that while the probe member 100 moves along the linear movement path with respect to the guide member 800, it deviate from the linear movement path. It is defined as restraining the movement of the probe member 100 and guiding the probe member 100 to move only along a straight movement path. In addition, guiding the rotation of the probe member 100 with respect to the guide member 800 suppresses the displacement of the rotational center of the probe member 100 with respect to the guide member 800 and rotates the probe member 100. It is defined as keeping the center constant.

The movement guide unit 900 may be configured to guide rotation and linear movement of the probe member 100 relative to the guide member 800 in various ways according to required conditions and design specifications.

For example, the movement guide unit 900 includes a guide groove 930 formed on the probe member 100 and a guide protrusion 830 formed on the guide member 800 to be movable along the guide groove 930. can include

When the guide protrusion 830 is accommodated in the guide groove 930, the movement of the guide protrusion 830 to the outside of the guide groove 930 is inhibited, so that the probe member 100 rotates with respect to the guide member 800 and It can guide linear movement. In addition, an entry groove 936 may be formed in the main body 120 of the probe member 100 to communicate with the guide groove 930, and the guide protrusion 830 passes through the entry groove 936 to guide the groove 930. ) is entered. For example, the entry groove 936 may be formed in a straight line along the longitudinal direction of the probe member 100 . In some cases, the entry groove may be formed in a curved shape or inclined with respect to the longitudinal direction of the probe member.

More specifically, the guide groove 930 includes a linear guide groove 932 formed on the outer surface of the body portion 120 of the probe member 100 along the length direction of the body portion 120, and a linear guide groove ( 132) and may include a rotation guide groove 934 formed on the outer surface of the body portion 120 along the circumferential direction of the body portion 120.

While the guide protrusion 830 moves along the linear guide groove 932, the linear movement of the probe member 100 relative to the guide member 800 is guided, and the guide protrusion 830 follows the rotation guide groove 934. During movement, rotation of the probe member 100 relative to the guide member 800 may be guided. Preferably, a plurality of rotation guide grooves 934 are provided to be spaced apart along the longitudinal direction of the probe member 100, and each rotation guide groove 934 may communicate with the linear guide groove 932.

The linear guide grooves 932 include a first section guide groove 932a formed between a pair of adjacent rotation guide grooves 934 and another one of the plurality of rotation guide grooves 934 adjacent to each other. It is formed between the pair and may include a second section guide groove (932b) disposed on the same line as the first section guide groove (932a) along the longitudinal direction of the probe member 100.

In this way, the first section guide groove 932a and the second section guide groove 932b constituting the linear guide groove 932 are arranged on the same line, so that the guide protrusion 830 is the first section guide. After moving along the groove 932a, it can directly enter the second section guide groove 932b. That is, the guide protrusion 830 moves along a straight line path passing through the first section guide groove 932a → the second section guide groove 932b. Depending on the condition of the patient, it may be difficult to perform treatment with the electrode 200 on a specific part of the mucous membrane (eg, a wound site). Accordingly, the linear movement of the probe member 100 relative to the guide member 800 is continuously performed in the first section guide groove 932a and the second section guide groove 932b, so that the electrode ( 200) can be passed through more quickly, thereby obtaining advantageous effects of shortening treatment time and increasing treatment efficiency.

However, the positions of the first section guide groove 932a and the second section guide groove 932b are not necessarily limited thereto, and the first section guide groove 932a and the second section guide groove 932b are on different lines. It is disposed on the guide member 800 so that the linear movement of the probe member 100 is performed in stages by the distance between each rotation guide groove 934, thereby increasing treatment efficiency and improving the safety and convenience of treatment. Examples are also possible.

In addition, a restraining groove 938 in which the guide protrusion 830 is accommodated and temporarily restrained may be formed in the guide groove 930 . For example, the restraining groove 938 may be formed in a hemispherical shape in which the guide protrusion 830 can be selectively accommodated or withdrawn. When the guide protrusion 830 is accommodated in the restraining groove 938, the arrangement of the guide protrusion 830 is restricted unless an external force (operator's operating force) is applied to the probe member 100. On the other hand, when an external force is applied to the probe member 100 while the guide protrusion 830 is accommodated in the restricting groove 938, the guide protrusion 830 comes out of the restricting groove 938. In this way, by forming the restriction groove 938 in the guide groove 930, the operator can feel a sense of manipulation when manipulating the probe member 100, and visually recognize the position of the electrode 200 relative to the mucous membrane. (For example, recognizing the position of the electrode 200 based on the reference position display unit 802) and tactile (sound and impact felt when the guide protrusion 830 is accommodated or withdrawn from the restraining groove 938) ) to be recognizable. For example, the restraining grooves 938 may be spaced apart from each other along the circumferential direction of the main body 120 . Preferably, the restraining grooves 938 may be spaced at regular intervals along the circumferential direction of the body portion 120 .

Although the present disclosure has been described through preferred embodiments as described above, the present invention is not limited thereto and various modifications and variations are possible without departing from the scope of the claims described below. Those in the field will easily understand.

100: probe member 110: head part
120: body part 200: electrode
300: motion detection sensor 400: drive motor
500: control unit 600: direction indicator unit
710: electrical coupling part 720: detachable part
800: guide member 900: moving guide unit

Claims (8)

a probe member including a head portion that approaches the mucous membrane of a treatment site and a body portion connected to the head portion;
an electrode installed in the head part and applying an electrical signal to blood vessels of the submucosal tissue of the mucosa;
a motion detection sensor installed in the head unit and detecting an operation of the head unit;
a control unit connected to the main body unit and adjusting the output of the electrical signal according to the motion of the head unit detected by the motion detection sensor;
an electrical coupling unit electrically attaching and detaching the head unit and the body unit;
a detachable part physically detachable from the head part and the main body part;
a guide member in which the probe member is selectively rotatably and linearly movable, and guides a position of the electrode relative to the mucous membrane of the treatment area; and
A movement guide unit for guiding rotation and linear movement of the probe member with respect to the guide member
including,
The electrical coupling part includes an electrical coupling pin installed in the body portion, and an electrical coupling plate installed in the head portion,
The electrical coupling pin is inserted into the electrical coupling groove of the electrical coupling plate and electrically coupled,
The detachable part includes a hook part installed in the body part and a hook part installed in the head part and coupled with the hook part,
Using a switch connected to one end of the hook part, the hook-shaped other end of the hook part is physically attached to and detached from the hooking part,
The movement guide portion includes a plurality of rotation guide grooves formed on an outer surface of the body portion along the circumferential direction of the body portion,
The switch is formed on the outer surface of the body portion, and is installed between adjacent rotation guide grooves. According to claim 1,
A driving motor installed in the main body and rotating the head
Including more,
The driving motor is controlled by the control unit treatment device for submucosal tissue. According to claim 2,
A direction indicating unit installed in the main body and displaying the rotation direction of the head unit
Submucosal tissue treatment device further comprising a. delete delete delete According to claim 1,
The motion detection sensor includes a gyro sensor or an acceleration sensor. delete

Images